The effectiveness of a novel treatment of TIM‐3(−) NK cells infusion in murine models of immune‐mediated bone marrow failure

BACKGROUND: T‐cell immunoglobulin and mucin‐containing domain (TIM)‐3 exerts its inhibitory effect on NK cells and participates in the immune pathogenesis of SAA. In this study, we aimed to explore a novel treatment method of TIM‐3(+) NK or TIM‐3(−) NK cell infusion in combination with immunosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Shaoxue, Zhang, Tian, Liu, Zixuan, Cui, Yi, Liu, Chunyan, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492454/
https://www.ncbi.nlm.nih.gov/pubmed/37539556
http://dx.doi.org/10.1002/jcla.24944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492454/
https://www.ncbi.nlm.nih.gov/pubmed/37539556
http://dx.doi.org/10.1002/jcla.24944

Ejemplares similares